Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2020 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
ORIC on Nasdaq
Shares outstanding
98,489,676
Price per share
$8.18
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
106,492,098
Total reported value
$1,277,897,890
% of total 13F portfolios
0%
Share change
+12,976,649
Value change
+$159,574,063
Number of holders
151
Price from insider filings
$8.18
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VIKING GLOBAL INVESTORS LP 10% +8.8% $95,149,860 +$23,507,430 8,729,345 +33% VIKING GLOBAL INVESTORS LP 30 Jun 2025
Nextech Crossover I GP S.a r.l. 8.4% $78,072,743 7,162,637 Nextech Crossover I GP S.a. r.l. 30 Jun 2025
EcoR1 Capital, LLC 6.9% $73,336,464 6,728,116 EcoR1 Capital, LLC 29 Jul 2025
Venrock Healthcare Capital Partners III, L.P. 7.7% +64% $35,029,459 +$18,130,241 6,596,885 +107% Venrock Healthcare Capital Partners III, L.P. 08 Apr 2025
SR ONE CAPITAL MANAGEMENT, LLC 4.8% -13% $50,307,686 4,615,384 0% SR One Capital Management, LLC 12 Aug 2025
ALKEON CAPITAL MANAGEMENT LLC 4.6% $54,049,152 4,504,096 Alkeon Capital Management LLC 30 Sep 2025
Point72 Asset Management, L.P. 5.1% $23,372,809 4,401,659 Point72 Asset Management, L.P. 29 May 2025
COLUMN GROUP II, LP 3.7% $48,612,534 3,644,118 Peter Svennilson 30 Sep 2025
BlackRock, Inc. 4.2% $36,744,188 3,620,224 BlackRock, Inc. 30 Jun 2025
FMR LLC 3.5% $13,967,797 2,467,809 FMR LLC 31 Dec 2024
Frazier Life Sciences Public Fund, L.P. 2% $7,981,692 1,410,193 James N. Topper 31 Mar 2025

As of 30 Sep 2025, 151 institutional investors reported holding 106,492,098 shares of Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC). This represents 108% of the company’s total 98,489,676 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) together control 90% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nextech Invest, Ltd. 7.3% 7,162,637 0% 13% $85,951,644
EcoR1 Capital, LLC 6.8% 6,728,116 +316% 3.9% $80,737,392
VR ADVISER, LLC 6.7% 6,596,885 0% 4.5% $79,162,620
VIKING GLOBAL INVESTORS LP 6.7% 6,572,700 0% 0.2% $78,872,400
Pfizer Inc 5.5% 5,376,344 0% 15% $64,516,128
BlackRock, Inc. 5.4% 5,276,620 +29% 0% $63,319,440
VANGUARD GROUP INC 4.7% 4,650,138 +49% 0% $55,801,656
SR One Capital Management, LP 4.6% 4,514,929 0% 7.8% $54,179,148
ALKEON CAPITAL MANAGEMENT LLC 4.6% 4,504,096 0% 0.24% $54,049,152
NEA Management Company, LLC 4.2% 4,118,621 0% 2.7% $49,423,452
ORBIMED ADVISORS LLC 3.7% 3,641,756 +305% 1% $43,701,072
Column Group LLC 3.6% 3,540,777 0% 52% $42,489,324
Vivo Capital, LLC 3.2% 3,126,604 0% 3% $37,519,248
PRICE T ROWE ASSOCIATES INC /MD/ 2.9% 2,871,327 +3.9% 0% $34,457,000
Point72 Asset Management, L.P. 2.7% 2,619,914 -8.1% 0.07% $31,438,968
FMR LLC 2.6% 2,528,048 +2.3% 0% $30,336,576
STATE STREET CORP 2.4% 2,403,939 +47% 0% $28,847,268
First Turn Management, LLC 2.2% 2,159,474 +7.4% 3.9% $25,913,688
SILVERARC CAPITAL MANAGEMENT, LLC 2% 1,948,808 +8.2% 3.4% $23,385,696
MPM BIOIMPACT LLC 1.8% 1,729,378 0% 3.4% $20,752,536
GEODE CAPITAL MANAGEMENT, LLC 1.7% 1,630,744 +47% 0% $19,573,783
Balyasny Asset Management L.P. 1.5% 1,519,314 -15% 0.04% $18,231,768
ROYCE & ASSOCIATES LP 1.5% 1,458,483 +521% 0.17% $17,501,796
JPMORGAN CHASE & CO 1.2% 1,228,528 -8% 0% $14,742,336
CITADEL ADVISORS LLC 1.2% 1,198,004 -15% 0.01% $14,376,048

Institutional Holders of Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 242,575 $1,984,754 +$463,859 $8.18 6
2025 Q3 106,492,098 $1,277,897,890 +$159,574,063 $12.00 151
2025 Q2 93,349,298 $947,499,065 +$169,716,912 $10.15 140
2025 Q1 79,209,337 $442,004,992 +$11,923,513 $5.58 142
2024 Q4 75,794,185 $611,682,254 -$16,308,147 $8.07 129
2024 Q3 69,823,199 $715,076,569 +$22,655,622 $10.25 121
2024 Q2 67,575,796 $477,762,911 +$20,174,043 $7.07 111
2024 Q1 63,945,767 $879,254,046 +$197,777,720 $13.75 110
2023 Q4 50,638,764 $465,880,631 +$34,655,080 $9.20 91
2023 Q3 48,053,106 $290,723,321 +$14,148,790 $6.05 89
2023 Q2 45,537,877 $353,374,535 +$99,111,683 $7.76 83
2023 Q1 33,075,099 $188,527,951 +$3,515,469 $5.70 70
2022 Q4 32,430,291 $192,141,081 +$135,543 $5.89 64
2022 Q3 32,701,288 $104,643,704 -$1,866,676 $3.20 69
2022 Q2 32,837,327 $147,127,000 -$6,223,365 $4.48 77
2022 Q1 33,856,070 $180,750,917 -$7,186,800 $5.34 94
2021 Q4 34,857,324 $512,119,938 -$36,775,082 $14.70 79
2021 Q3 31,534,174 $659,370,855 +$8,490,366 $20.91 78
2021 Q2 36,145,561 $639,409,737 +$2,954,162 $17.69 78
2021 Q1 35,685,685 $874,284,848 +$71,774,159 $24.50 82
2020 Q4 32,607,853 $1,103,814,951 +$273,075,064 $33.85 76
2020 Q3 22,151,969 $552,859,000 +$7,647,968 $25.01 53
2020 Q2 21,388,813 $718,339,063 +$718,339,063 $33.73 64